Susan M Blaney Selected Research

Therapeutics

1/2022	Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report.
1/2021	Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912).
1/2020	A phase I/II study of veliparib (ABT-888) with radiation and temozolomide in newly diagnosed diffuse pontine glioma: a Pediatric Brain Tumor Consortium study.
1/2020	A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.
1/2015	Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium.
7/2014	A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study.
9/2013	A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study.
9/2013	A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study.
5/2013	Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
4/2013	A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan M Blaney Research Topics

Disease

101	Neoplasms (Cancer) 01/2021 - 02/2003
23	Brain Neoplasms (Brain Tumor) 01/2020 - 08/2004
19	Glioma (Gliomas) 01/2020 - 04/2004
19	Leukemia 01/2019 - 11/2004
17	Neutropenia 01/2020 - 11/2006
13	Thrombocytopenia (Thrombopenia) 04/2015 - 12/2004
11	Medulloblastoma 09/2013 - 12/2005
10	Fatigue 01/2020 - 07/2004
9	Ewing Sarcoma (Sarcoma, Ewing) 01/2020 - 11/2006
8	Neuroblastoma 01/2021 - 11/2006
8	Central Nervous System Neoplasms 01/2020 - 03/2007
8	Vomiting 02/2018 - 11/2004
8	Nausea 05/2015 - 08/2004
7	Diarrhea 11/2012 - 11/2004
6	Exanthema (Rash) 01/2020 - 06/2008
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 05/2007
5	Ependymoma 01/2021 - 06/2010
5	Osteosarcoma (Osteogenic Sarcoma) 01/2016 - 11/2006
5	Rhabdomyosarcoma 09/2015 - 03/2008
5	Anemia 05/2015 - 08/2011
5	Sarcoma (Soft Tissue Sarcoma) 03/2015 - 11/2006
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2020 - 05/2013
4	Hypertension (High Blood Pressure) 01/2020 - 11/2012
4	Meningitis 04/2013 - 01/2003
4	Anorexia 03/2013 - 07/2004
4	Hypokalemia 08/2011 - 04/2009
4	Headache (Headaches) 04/2009 - 01/2005
3	Diffuse Intrinsic Pontine Glioma 01/2022 - 01/2020
3	Disease Progression 01/2021 - 09/2005
3	Hemorrhage 01/2020 - 04/2007
3	Mucositis 01/2017 - 11/2012
3	Lymphopenia (Lymphocytopenia) 05/2015 - 08/2011
3	Leukopenia 05/2015 - 07/2004
3	Hypocalcemia 08/2011 - 02/2003
3	Abdominal Pain (Pain, Abdominal) 04/2010 - 01/2008
3	Primitive Neuroectodermal Tumors (PNET) 11/2006 - 12/2005
2	Hypersensitivity (Allergy) 01/2018 - 03/2009
2	Lymphoma (Lymphomas) 01/2018 - 01/2008
2	Wilms Tumor (Wilm's Tumor) 09/2015 - 01/2010
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 09/2014 - 01/2006
2	Plexiform Neurofibroma 09/2014 - 01/2006
2	Infections 09/2013 - 06/2008
2	Proteinuria 08/2013 - 08/2006
2	Arachnoiditis 04/2013 - 03/2006
2	Hypophosphatemia 02/2013 - 08/2011

Drug/Important Bio-Agent (IBA)

10	Biological ProductsIBA 01/2016 - 08/2006
9	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 11/2007
8	Alanine Transaminase (SGPT)IBA 02/2018 - 11/2006
6	Imatinib Mesylate (Gleevec)FDA Link 03/2011 - 04/2004
5	CrizotinibIBA 01/2021 - 05/2013
5	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 12/2005
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015 - 04/2007
5	Pharmaceutical PreparationsIBA 09/2013 - 07/2005
5	ErbB Receptors (EGF Receptor)IBA 09/2013 - 09/2005
5	Topotecan (Hycamtin)FDA LinkGeneric 04/2013 - 01/2003
5	Irinotecan (Camptosar)FDA LinkGeneric 04/2010 - 02/2003
4	dipinacoline glutamateIBA 01/2022 - 02/2018
4	Vorinostat FDA Link 01/2022 - 08/2010
4	veliparibIBA 01/2020 - 08/2009
4	Alkaline PhosphataseIBA 01/2017 - 08/2011
4	Tyrosine Kinase InhibitorsIBA 01/2016 - 04/2004
4	CreatinineIBA 10/2015 - 08/2006
4	cixutumumabIBA 04/2015 - 01/2012
4	EnzymesIBA 05/2013 - 07/2004
4	Bortezomib (Velcade)FDA Link 03/2013 - 12/2004
4	Transaminases (Aminotransferases)IBA 08/2011 - 11/2004
3	Histone Deacetylase InhibitorsIBA 01/2022 - 08/2006
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020 - 02/2010
3	Sunitinib (Sutent)FDA Link 01/2016 - 08/2011
3	Biomarkers (Surrogate Marker)IBA 03/2015 - 09/2007
3	Histone Deacetylases (Histone Deacetylase)IBA 09/2013 - 08/2006
3	Amylases FDA Link 08/2013 - 03/2008
3	Lipase (Acid Lipase)FDA Link 08/2013 - 03/2008
3	Pemetrexed (MTA)FDA Link 02/2013 - 03/2007
3	mafosfamideIBA 09/2012 - 01/2005
3	tipifarnib (R115777)IBA 02/2011 - 01/2006
3	Gefitinib (Iressa)FDA Link 12/2010 - 09/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2010 - 07/2006
3	Farnesyltranstransferase (Farnesyltransferase)IBA 06/2008 - 01/2006
3	Proteasome InhibitorsIBA 03/2007 - 12/2004
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 05/2013
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2008
2	MLN 8237IBA 01/2019 - 11/2012
2	Capecitabine (Xeloda)FDA Link 02/2018 - 06/2013
2	TabletsIBA 02/2018 - 06/2013
2	Asparaginase (Elspar)FDA Link 01/2018 - 07/2006
2	Gemcitabine FDA Link 01/2018 - 07/2008
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2016 - 02/2008
2	Sorafenib (BAY 43-9006)FDA Link 09/2015 - 11/2012
2	temsirolimus FDA Link 04/2015 - 03/2015
2	ElectrolytesIBA 03/2015 - 01/2008
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2014 - 08/2009
2	Proteins (Proteins, Gene)FDA Link 09/2013 - 12/2010
2	Lapatinib (GW572016)FDA Link 09/2013 - 09/2010

Therapy/Procedure

25	Therapeutics 01/2022 - 12/2004
9	Drug Therapy (Chemotherapy) 12/2020 - 01/2005
8	Radiotherapy 01/2022 - 04/2006
4	Intravenous Infusions 02/2013 - 11/2006
3	Lasers (Laser) 08/2012 - 01/2008
2	Intravenous Injections 09/2013 - 01/2011